Crossmark

Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza

Published Online: 2016-09-27

Published Print: 2017-04

Authors

Smith, Amber M.
Funding

Funding for this research was provided by:

National Institute of Allergy and Infectious Diseases (AI100946)

National Institute of Allergy and Infectious Diseases (AI125324)
License Information

Text and Data Mining valid from 2016-09-27

Version of Record valid from 2016-09-27
More Information

Article History

Received: 1 June 2016

Accepted: 17 September 2016

First Online: 27 September 2016

Document is current